Sandy Spring Bank’s NeoGenomics NEO Stock Holding History

Sandy Spring Bank’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-150	Closed	-$2.21K	–	1265
2024 Q3	$2.21K	Hold	150	–	–	﹤0.01%	1029
2024 Q2	$2.08K	Hold	150	–	–	﹤0.01%	1091
2024 Q1	$2.36K	Hold	150	–	–	﹤0.01%	1036
2023 Q4	$2.43K	Hold	150	–	–	﹤0.01%	999
2023 Q3	$1.84K	Hold	150	–	–	﹤0.01%	1037
2023 Q2	$2.41K	Hold	150	–	–	﹤0.01%	1048
2023 Q1	$2.61K	Hold	150	–	–	﹤0.01%	1005
2022 Q4	$1.39K	Hold	150	–	–	﹤0.01%	1046
2022 Q3	$1K	Hold	150	–	–	﹤0.01%	1098
2022 Q2	$1K	Hold	150	–	–	﹤0.01%	1097
2022 Q1	$2K	Hold	150	–	–	﹤0.01%	1063
2021 Q4	$5K	Sell	150 -50	-25%	-$1.96K	﹤0.01%	1024
2021 Q3	$10K	Buy	+200	New	+$9.26K	﹤0.01%	877

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sandy Spring Bank's NEO Position: Q4 2024 in Review

Sandy Spring Bank sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 150 shares — an estimated $2.21K sold.

Sandy Spring Bank first reported a position in NEO in Q3 2021 and held it in 13 quarters. The position peaked at $10K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

Sandy Spring Bank reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
Sandy Spring Bank sold 150 NeoGenomics shares in Q4 2024, an estimated $2.21K.
Sandy Spring Bank first reported a position in NeoGenomics in Q3 2021 and held it in 13 quarters.
Sandy Spring Bank's NeoGenomics position peaked at $10K in Q3 2021.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Sandy Spring Bank's 13F filing for Q4 2024, filed 11 Feb 2025.